WO2008141751A3 - Pharmaceutical compositions comprising oxcarbazepine - Google Patents

Pharmaceutical compositions comprising oxcarbazepine Download PDF

Info

Publication number
WO2008141751A3
WO2008141751A3 PCT/EP2008/003814 EP2008003814W WO2008141751A3 WO 2008141751 A3 WO2008141751 A3 WO 2008141751A3 EP 2008003814 W EP2008003814 W EP 2008003814W WO 2008141751 A3 WO2008141751 A3 WO 2008141751A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical compositions
oxcarbazepine
less
particle size
relates
Prior art date
Application number
PCT/EP2008/003814
Other languages
French (fr)
Other versions
WO2008141751A2 (en
Inventor
Satish G Dhonde
Ganesh V Gat
Jawed Hussain
Original Assignee
Ratiopharm Gmbh
Satish G Dhonde
Ganesh V Gat
Jawed Hussain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ratiopharm Gmbh, Satish G Dhonde, Ganesh V Gat, Jawed Hussain filed Critical Ratiopharm Gmbh
Priority to EP08758478A priority Critical patent/EP2146699A2/en
Publication of WO2008141751A2 publication Critical patent/WO2008141751A2/en
Publication of WO2008141751A3 publication Critical patent/WO2008141751A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to pharmaceutical compositions containing Oxcarbazepine having a median particle size of about 2 μm or less.
PCT/EP2008/003814 2007-05-23 2008-05-13 Pharmaceutical compositions comprising oxcarbazepine WO2008141751A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP08758478A EP2146699A2 (en) 2007-05-23 2008-05-13 Pharmaceutical compositions comprising oxcarbazepine

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1078CH2007 2007-05-23
IN1078/CHE/2007 2007-05-23

Publications (2)

Publication Number Publication Date
WO2008141751A2 WO2008141751A2 (en) 2008-11-27
WO2008141751A3 true WO2008141751A3 (en) 2009-07-16

Family

ID=39679291

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/003814 WO2008141751A2 (en) 2007-05-23 2008-05-13 Pharmaceutical compositions comprising oxcarbazepine

Country Status (2)

Country Link
EP (1) EP2146699A2 (en)
WO (1) WO2008141751A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2968354B1 (en) * 2013-03-15 2019-11-13 Aprecia Pharmaceuticals LLC Rapidly dispersible dosage form of oxcarbazepine
WO2015063670A1 (en) * 2013-10-30 2015-05-07 Wockhardt Limited Solid oral modified-release composition comprising oxcarbazepine or a pharmaceutically acceptable salt thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998035681A1 (en) * 1997-02-14 1998-08-20 Novartis Ag Oxacarbazepine film-coated tablets
WO2002094774A2 (en) * 2001-05-18 2002-11-28 Ranbaxy Laboratories Limited Oxcarbazepine dosage forms
EP1815849A1 (en) * 2006-01-31 2007-08-08 Teva Pharmaceutical Industries Ltd Oxcarbazepine pharmaceutical formulation and its method of preparation, wherein oxcarbazepine has a broad and multi-modal particle size distribution

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998035681A1 (en) * 1997-02-14 1998-08-20 Novartis Ag Oxacarbazepine film-coated tablets
WO2002094774A2 (en) * 2001-05-18 2002-11-28 Ranbaxy Laboratories Limited Oxcarbazepine dosage forms
EP1815849A1 (en) * 2006-01-31 2007-08-08 Teva Pharmaceutical Industries Ltd Oxcarbazepine pharmaceutical formulation and its method of preparation, wherein oxcarbazepine has a broad and multi-modal particle size distribution

Also Published As

Publication number Publication date
WO2008141751A2 (en) 2008-11-27
EP2146699A2 (en) 2010-01-27

Similar Documents

Publication Publication Date Title
ME03786B (en) Pharmaceutical compositions of the amorphous form of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
WO2008064353A3 (en) 7,8-saturated-4,5-epoxy-morphinanium analogs
WO2010068471A3 (en) Sensitivity oral care compositions
WO2011077043A3 (en) Phenol derivatives and pharmaceutical or cosmetic use thereof
WO2007101551A3 (en) Phospholipid complexes of curcumin having improved bioavailability
WO2010069532A8 (en) Antibodies against human angiopoietin 2
WO2011069063A3 (en) Multicyclic compounds and methods of use thereof
WO2008070462A3 (en) N-oxides of 4,5-epoxy-morphinanium analogs
IL196226A0 (en) Phosphonate and phosphinate compounds and pharmaceutical compositions containing the same
WO2012042371A3 (en) Pharmaceutical composition
WO2011107186A3 (en) Compounds for electronic devices
PL2083809T3 (en) Dietary or pharmaceutical compositions containing tricyclic diterpenes for the treatment of depression.
WO2010122332A3 (en) Xanthan gum and swellable particulate containing composition and uses thereof
WO2007075381A3 (en) Pharmaceutical compositions of ilaprazole
WO2006133006A3 (en) 1-methyl-1h-pyrazole-4-carboxamides useful as cancer chemotherapeutic agents
WO2008154234A3 (en) Extended release formulation of nevirapine
WO2012025828A3 (en) Superfine powdered stevia
WO2007128639A3 (en) Novel hydrophobically modified cationic polymers and personal care compositions thereof
WO2009102707A3 (en) Substituted oxazaphosphorines
WO2008081268A3 (en) Pharmaceutical compositions of entacapone
TWI340042B (en) Preparation of anti-dandruff bioactives from sapindus mukorossi and extended products containing the bioactives.
WO2008141751A3 (en) Pharmaceutical compositions comprising oxcarbazepine
ME01542B (en) Anticancer compound and pharmaceutical composition containing the same
WO2009060064A3 (en) Pharmaceutical formulations for the oral administration of ppi
WO2009016608A3 (en) Pharmaceutical compositions of fenofibrate

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08758478

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2008758478

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE